Antimicrobial resistance (AMR) continues to severely affect global health and the global economy. It is one of the most serious public health threats of the 21^st century, exacerbated by antibiotic overuse and misuse worldwide. It is responsible for 700,000 deaths annually and is predicted to cause more than 10 million deaths by 2050. It is essential to take the One Health approach to effectively address the AMR issue. The concept of One Health refers to an all-encompassing strategy for improving the well-being of people, animals, and the environment.

To enable and support One Health, TechInvention employs four strategies: research and development, contract development and manufacturing for scale-ups and commercial production, technical and strategic advisory for capacity building, and global access to diagnostics, vaccines, and biopharmaceuticals.